Cerity Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 15,548 shares of REGN stock, worth $11.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

15,548

Previous 13,125 18.46%

Holding current value

$11.1 Million

Previous $13.8 Million 18.49%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $2.48 Million - $2.91 Million	2,423 Added 18.46%	15,548 $16.3 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $1.61 Million - $1.95 Million	-1,819 Reduced 12.17%	13,125 $13.8 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $3.15 Million - $3.46 Million	3,486 Added 30.42%	14,944 $14.4 Million
Q4 2023 Jan 26, 2024	BUY	$775.18 - $881.7 $6.12 Million - $6.96 Million	7,897 Added 221.76%	11,458 $10.1 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $4.08 Million - $4.97 Million	-5,890 Reduced 62.32%	3,561 $2.93 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $140,006 - $166,070	200 Added 2.16%	9,451 $6.79 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $29,941 - $36,386	44 Added 0.48%	9,251 $7.6 Million
Q4 2022 Feb 15, 2023	BUY	$705.89 - $766.39 $256,238 - $278,199	363 Added 4.1%	9,207 $6.64 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $16,071 - $20,280	28 Added 0.32%	8,844 $6.09 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $1.41 Million - $1.91 Million	2,579 Added 41.35%	8,816 $5.21 Million
Q1 2022 Apr 25, 2022	SELL	$595.12 - $698.43 $1.66 Million - $1.95 Million	-2,789 Reduced 30.9%	6,237 $4.36 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $1.75 Million - $2.16 Million	3,221 Added 55.49%	9,026 $5.7 Million
Q3 2021 Oct 25, 2021	SELL	$574.03 - $680.96 $19,517 - $23,152	-34 Reduced 0.58%	5,805 $3.51 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $74,229 - $87,690	157 Added 2.76%	5,839 $3.26 Million
Q1 2021 Aug 11, 2021	SELL	$446.73 - $548.2 $35,291 - $43,307	-79 Reduced 1.37%	5,682 $2.69 Million
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $40,205 - $49,338	90 Added 1.59%	5,761 $2.73 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $291,284 - $370,259	609 Added 12.03%	5,671 $2.74 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $135,642 - $163,894	249 Added 5.17%	5,062 $2.83 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $101,623 - $132,647	206 Added 4.47%	4,813 $3 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $170,779 - $251,170	508 Added 12.39%	4,607 $2.25 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $169,960 - $233,436	-620 Reduced 13.14%	4,099 $1.54 Million
Q3 2019 Oct 30, 2019	BUY	$273.46 - $318.39 $23,244 - $27,063	85 Added 1.83%	4,719 $1.31 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $25,466 - $35,259	85 Added 1.87%	4,634 $1.45 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $106,042 - $125,277	-285 Reduced 5.9%	4,549 $1.87 Million
Q4 2018 Feb 06, 2019	BUY	$335.82 - $403.04 $30,223 - $36,273	90 Added 1.9%	4,834 $1.81 Million
Q3 2018 Nov 15, 2018	BUY	$351.14 - $408.51 $55,128 - $64,136	157 Added 3.42%	4,744 $1.92 Million
Q2 2018 Aug 15, 2018	BUY	$284.6 - $344.99 $32,729 - $39,673	115 Added 2.57%	4,587 $1.58 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $1.41 Million - $1.76 Million	4,472 New	4,472 $1.54 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $2.27 Million - $2.98 Million	-6,340 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $2.73 Million - $3.2 Million	6,340	6,340 $2.84 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History